Protracted Adjuvant Temozolomide in Glioblastoma Multiforme
Dina Salem
Journal of Cancer Therapy, 2015
View PDFchevron_right
Another Cause of Pancytopenia in a Patient Receiving Temozolomide
Celaletdin Camci
Medical Principles and Practice, 2011
View PDFchevron_right
Severe and Prolonged Myelosuppression during Concomitant Temozolomide and Radiotherapy Treatment in a Patient with Glioblastoma Multiforme
Maurizio Simmaco
International Journal of Medical and Pharmaceutical Case Reports, 2015
View PDFchevron_right
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Ana-Maria Florea
Journal of Neurochemistry, 2012
View PDFchevron_right
MGMTGene Silencing and Benefit from Temozolomide in Glioblastoma
Johan Kros
The New England Journal of Medicine, 2005
View PDFchevron_right
Randomized Study of Postoperative Radiotherapy and Simultaneous Temozolomide without Adjuvant Chemotherapy for Glioblastoma
Peter Frommolt
Strahlentherapie und Onkologie, 2008
View PDFchevron_right
Extended-schedule dose-dense temozolomide in refractory gliomas
Miguel Angel Garcia Gil
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study
Jannick Brennum
Molecular Oncology, 2021
View PDFchevron_right
Glioblastoma: Therapeutic challenges, what lies ahead
Luciana Romão
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
View PDFchevron_right
Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide
Martin Van Den Bent
Cancer, 2008
View PDFchevron_right
Glioma Cell Biology
Aleksi Šedo
2014
View PDFchevron_right
Clinicohaematological Spectrum of Pancytopenia in a Tertiary Care Hospital
Taj Yousaf Khan
Journal of Postgraduate Medical Institute, 2013
View PDFchevron_right
Prognostic impact of hemoglobin level and other factors in patients with high-grade gliomas treated with postoperative radiochemotherapy and sequential chemotherapy based on temozolomide
Giampiero Cèfaro
Strahlentherapie und Onkologie, 2011
View PDFchevron_right
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma
Giacomo Signorino
Oncotarget, 2017
View PDFchevron_right
Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma
Ting-Chao Chou
Cancer Gene Therapy, 2001
View PDFchevron_right
Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study
ALESSANDRO PAPPALARDO
Lung Cancer, 2005
View PDFchevron_right
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients
Surein Arulananda
Internal medicine journal, 2018
View PDFchevron_right
The SIAH1–HIPK2–p53ser46 Damage Response Pathway is Involved in Temozolomide-Induced Glioblastoma Cell Death
Bernd Kaina
Molecular Cancer Research, 2019
View PDFchevron_right
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
C. Von Arx
Journal of Translational Medicine, 2016
View PDFchevron_right
Analysis of temozolomide treated glioblastoma multiforme patients
Leo Lahti
2011
View PDFchevron_right
Pancytopenia and Acute Febrile Illness in a Female
Nitin Malhotra
Laboratory Medicine, 2009
View PDFchevron_right
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial
Johan Kros
Clinical Cancer Research, 2022
View PDFchevron_right
Methotrexate-induced pancytopenia: a case series of 46 patients
Richa Mishra
International Journal of Rheumatic Diseases, 2017
View PDFchevron_right
Combination hyperbaric oxygen and temozolomide therapy in c6 rat glioma model
AKIN SAVAŞ TOKLU
Acta Cirurgica …, 2012
View PDFchevron_right
Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas
Naoko Takebe
Oncotarget, 2020
View PDFchevron_right
Virology of Malignant Brain Tumours
Sheryl Green
2013
View PDFchevron_right
Immune infiltration, glioma stratification, and therapeutic implications
Sarmistha Talukdar
Translational Cancer Research, 2016
View PDFchevron_right
Immunotherapeutic Strategies for Malignant Glioma
Robert Fenstermaker
Cancer Control, 2004
View PDFchevron_right
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
Eleonora Swart
Cancers, 2023
View PDFchevron_right
Going past the data for temozolomide
Nathalie Letarte
Cancer Chemotherapy and Pharmacology, 2011
View PDFchevron_right
Glioblastoma in multiple sclerosis: a case report
Alessandro Cianfoni
Journal of Neuro-Oncology, 2009
View PDFchevron_right
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
Gary Archer
2000
View PDFchevron_right
Review: On TRAIL for malignant glioma therapy?
Wijnand Helfrich
Neuropathology and Applied Neurobiology, 2010
View PDFchevron_right
Aspergillosis in a Patient Receiving Temozolomide for the Treatment of Glioblastoma
Olavo Feher
Case Reports in Oncology, 2013
View PDFchevron_right
Tumores presacros. Análisis de nuestra experiencia en 20 casos tratados quirúrgicamente
Vicente Pla
Cirugía Española, 2010
View PDFchevron_right